SCOR (SCR) Investor update summary
Event summary combining transcript, slides, and related documents.
Investor update summary
4 Feb, 2026Renewal outcomes and portfolio development
Achieved 4.7% EGPI growth in traditional reinsurance and 80.5% in Alternative Solutions at January 2026 renewals, contributing to a total EGPI growth of 14.8%.
Net underwriting ratio improved by 2.0 percentage points, with a below 87% net combined ratio target for 2026.
Selective growth focused on P&C lines and key clients, especially in APAC and North America, with Property Cat premiums up 12.5%.
Specialty lines premium income was flat, with growth in some areas and reductions in others due to competition and margin protection.
Approximately two-thirds of P&C reinsurance EGPI was renewed at 1.1.2026, representing about half of total P&C premiums.
Market environment and pricing trends
Ample capacity and increased reinsurance demand led to competitive pricing, with a -1.9% overall gross price change and Cat XL rates declining by 12%.
Non-proportional lines saw the largest price adjustments, while proportional placements varied by market and line.
Retrocession market was highly competitive, enabling optimization of placements and higher ceding commissions, with structure broadly unchanged.
Price adequacy remains high for Cat, especially in the US, while specialty lines like marine and engineering faced more pressure; cyber and aviation did not harden as expected.
Market discipline maintained on structures and terms despite intensified competition.
Strategic focus and outlook
Continued emphasis on selective growth, underwriting discipline, and active portfolio steering to maintain resilience and profitability.
Alternative Solutions growth driven by client demand for customized, capital-efficient transactions, with positive but limited impact on the group combined ratio.
No significant change in Nat Cat share expected for 2026; future strategy may be revisited in the next planning cycle.
April, June, and July renewals expected to remain competitive, with less pronounced price adjustments than January.
Positioning as a nimble, global reinsurer with broad client solutions and strong client relationships, benefiting from panel consolidation among cedants.
Latest events from SCOR
- FY net income up to EUR 851M, ROE above 19%, dividend EUR 1.9/share, solvency 215%.SCR
Q4 20254 Mar 2026 - Q2 2024 net loss driven by L&H review, but P&C and solvency remain strong.SCR
Q2 202410 Feb 2026 - H1 2025 net income EUR 425m, ROE 20.3%, P&C combined ratio 82.5%, solvency 210%.SCR
Q2 202510 Feb 2026 - Strong P&C and investment results offset by L&H review, solvency robust at 203%.SCR
Q3 202414 Jan 2026 - Forward 2026 targets 9% value growth, >12% ROE, higher-margin L&H, and robust solvency.SCR
Investor Day 202411 Jan 2026 - 9.6% EGPI growth driven by Specialty and Alternative Solutions, with stable profitability.SCR
Investor Update9 Jan 2026 - Q4 2024 net income EUR 233m, adjusted FY net income EUR 728m, solvency at 210%, dividend EUR 1.8.SCR
Q4 202413 Dec 2025 - Q1 2025 net income hit EUR 200m, with robust solvency and strong segment performance.SCR
Q1 202518 Nov 2025 - Q3 2025 delivered EUR 217m net income, 21.5%–22.1% ROE, and a 210% solvency ratio.SCR
Q3 20252 Nov 2025